Skip to main content
. 2017 Sep;33(5):477–485. doi: 10.6515/ACS20170603A

Supplement Table 1. Baseline characteristics of study population grouping by different types of myocardial infarction (MI, included STEMI and NSTEMI).

STEMI (N = 116) NSTEMI (N = 214) p value
Age (years) 69.2 ± 15.8 72.7 ± 14.8 0.052
Male, n (%) 94 (81.0) 152 (72.0) 0.162
SBP (mmHg) 131 ± 34.4 135 ± 28.3 0.086
Heart rate (beats/min) 85.0 ± 21.0 85.0 ± 20.6 0.590
Respiratory rate (rates/min) 20.3 ± 4.1 20.5 ± 3.6 0.582
Body temperature (°C) 36.4 ± 0.6 36.2 ± 1.1 0.500
Current smoker, n (%) 27 (23.2) 41 (19.2) 0.583
Diabetes mellitus, n (%) 44 (37.9) 102 (47.7) 0.089
Hypertension, n (%) 74 (63.8) 160 (74.7) 0.036
Heart failure, n (%) 5 (4.3) 214 (14.5) 0.005
Medications, n (%)
 Aspirin 24 (20.7) 61 (28.5) 0.134
 Beta blocker 18 (15.5) 55 (25.7) 0.038
 ACEi 10 (8.6) 24 (11.2) 0.473
Laboratory data
 White blood cell (103/cumm) 13.4 ± 21.5 11.1 ± 12.2 0.161
 Segment (%) 74.5 ± 13.7 75.0 ± 12.1 0.531
 Hemoglobin (g/dl) 13.0 ± 2.5 12.1 ± 2.7 0.433
 Creatitine (mg/dl) 1.6 ± 1.3 2.3 ± 1.6 0.001
 CRP (mg/dl) 4.4 ± 5.8 3.9 ± 6.1 0.556
 Initial CK (mg/dL) 471.5 ± 1043.0 326.2 ± 541.0 0.010
 Peak CK (mg/dl) 1646.6 ± 2672.2 789.7 ± 1541.2 0.001
 LVEF (%) 49.0 ± 11.1 47.9 ± 11.9 0.449
Location of vascular lesions 0.482
 LAD 69 (59.5) 111 (51.9)
 LCX 56 (48.3) 103 (48.1)
 RCA 64 (55.2) 114 (53.3)
Total revascularization 48 (41.4) 40 (18.7) 0.032
CIN after procedure 4 (3.4) 15 (7.0) 0.185

ACEi, angiotensin converting enzyme inhibitor; CABG, coronary artery bypass surgery; CIN, contrast induce nephropathy; CK, creatine kinase; CRP, C-reactive protein; LAD, left anterior descending artery; LCX, left circumflex artery; LVEF, left ventricular ejection fraction; NSTEMI, non-ST elevation MI; RCA, right coronary artery; SBP, systolic blood pressure; STEMI, ST elevation MI.